Literature DB >> 634335

The evolution of therapeutic research in cancer.

V T DeVita.   

Abstract

Entities:  

Mesh：

Year:  1978        PMID： 634335     DOI： 10.1056/NEJM197804202981610

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Presidential address: Tumoribus praeter naturam.

Authors:  E M Bricker
Journal:  Ann Surg       Date:  1985-09       Impact factor: 12.969

Review 2.  Antibody-Drug Conjugates: Pharmacokinetic/Pharmacodynamic Modeling, Preclinical Characterization, Clinical Studies, and Lessons Learned.

Authors:  William D Hedrich; Tamer E Fandy; Hossam M Ashour; Hongbing Wang; Hazem E Hassan
Journal:  Clin Pharmacokinet       Date:  2018-06       Impact factor: 6.447

Review 3.  Predictive tests in cancer chemotherapy. A reappraisal.

Authors:  R Osieka; S Seeber; C G Schmidt
Journal:  Klin Wochenschr       Date:  1984-03-01

Review 4.  Recent Trends of the Bio-Inspired Nanoparticles in Cancer Theranostics.

Authors:  Vijay Sagar Madamsetty; Anubhab Mukherjee; Sudip Mukherjee
Journal:  Front Pharmacol       Date:  2019-10-25       Impact factor: 5.810

Review 5.  Encapsulation, Release, and Cytotoxicity of Doxorubicin Loaded in Liposomes, Micelles, and Metal-Organic Frameworks: A Review.

Authors:  Mihad Ibrahim; Waad H Abuwatfa; Nahid S Awad; Rana Sabouni; Ghaleb A Husseini
Journal:  Pharmaceutics       Date:  2022-01-21       Impact factor: 6.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.